Delivery Order SPE2DB20D6035-SPE2DB25FLYFV
- Not listed
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The order is for 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a potential value of $1,459.16. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Lisinopril-HCTZ 20-25 mg tablets, with a ceiling value of $1,150.62. The contract is for a fixed price and has an ultimate completion date of June 24, 2025. The contract is not set aside for any specific small business designation. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,566,088 units of Lisinopril-HCTZ 20-25 mg tablets, with a ceiling value of $1,027.91 and a period of performance through October 15, 2024. AmerisourceBergen has been awarded multiple federal contracts and Indefinite Delivery Contracts (IDCs) by DLA and other agencies, including a $999,999,999 IDC with DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,048.21, is for the supply of Lisinopril-HCTZ 10-12.5 mg tablets in 1,000 tablet quantities. The contract has an ultimate completion date of August 13, 2024 and is a Firm Fixed Price contract. This order is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-25 mg. The single-award, firm-fixed price delivery order, valued at $2,066.47, has a completion date of July 28, 2022. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the drug Lisinopril-HCTZ 20-12.5 mg tablets, with a firm fixed price of $1,126.61 and a performance period through May 13, 2025. The contract is not set aside for any small business category. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,556,110,689 lisinopril 20 mg tablets in lots of 1,000. This $1,056.28 award is not associated with any set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on a larger $999,999,999.00 indefinite delivery contract with DLA to deliver pharmaceutical products and medical...
- The Defense Logistics Agency awarded a $24,220 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 1,000 tablets of 40mg lisinopril. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 18-19, 2023. No additional details were provided regarding the original solicitation or whether this delivery order was placed against an existing Government-Wide Acquisition Contract vehicle or set-aside...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of 4,563,970,033 units of the prescription drug Lisinopril-HCTZ 20-25 mg tablets in 500 count packages. The order has a ceiling value of $1,542.24 and an ultimate completion date of March 15, 2024. Amerisourcebergen Drug Corp is an experienced government contractor, holding an Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,524.61 fixed-price delivery order contract is for the supply of LISINOPRIL-HCTZ 20-25 MG TAB 500S, a cardiovascular medication. The contract has an ultimate completion date of March 12, 2025 and is not designated with any set-aside requirements. This award is associated with a larger Indefinite Delivery Contract...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB25FLYFVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of 1,000 tablets of Lisinopril-HCTZ 20-25 mg at a ceiling value of $1,344.35. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract has an ultimate completion date of August 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. This prime pharmaceutical supply vehicle provides comprehensive global support for military healthcare programs, enabling AmerisourceBergen to deliver a broad range of generic and brand-name medications, vaccines, and medical supplies to defense and veteran healthcare systems. The DLA Troop Support Medical program represents a strategic approach to pharmaceutical procurement, with plans underway to establish next-generation contracts that will involve multiple regional awards to ensure robust supply chain capability across the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 8/20/25 |